Miracle

Miracle Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and manufacturing of high-quality medicines across several therapeutic areas, including metabolic diseases, cardiovascular health, and gastroenterology. The company operates integrated facilities for both Active Pharmaceutical Ingredient (API) production and finished dosage forms, ensuring a robust supply chain for its domestic and international markets. Miracle Pharmaceutical is particularly recognized for its work in the diabetes space, developing both generic and innovative treatments such as GLP-1 receptor agonists. With a strong emphasis on R&D and GMP-compliant manufacturing, the company aims to provide affordable and effective healthcare solutions globally.